Plunkett Research Online: MeiraGTx Holdings PLC

MEIRAGTX HOLDINGS PLC (MGTX:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It is engaged in the development of innovative gene therapy products to transform the lives of patients suffering from acquired and inherited disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3. AAV-UPF1, and others......



MeiraGTx Holdings PLC
Ticker: MGTX
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 646 490-2965
Fax:
Address: 430 East 29th Street
14th Floor
New York, NY 10016 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Biological Product (except Diagnostic) Manufacturing
Contacts Description

Alexandria Forbes CEO/Director/President
Richard Giroux CFO/COO
See More
MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It is engaged in the development of innovative gene therapy products to transform the lives of patients suffering from acquired and inherited disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3. AAV-UPF1, and others......See More See More

Auditor: EY
Legal Advisor:
$USD, In whole numbers,
except marked * or %
2020 2019 2018 2017 2016
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and Affiliates Top Salaries
Name Title Salary (US$) Bonus (US$)
Other Thoughts Corporate Culture

Apparent Female Officers or Directors: